Carbonel, Jeanvie .

HRN: 28-25-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/13/2026
02/15/2026
IV
500mg
Q8
Sp CS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: